Plasminogen Activator Inhibitor (PAI-1) Ag
Test Code
36555
85415
Clinical Significance
Plasminogen Activator Inhibitor (PAI-1) Ag -
Increased activity is associated with increased risk of arterial thrombosis, such as with unexplained premature myocardial infarction. As an acute phase reactant, the activity is increased after an acute event. Studies suggest PAI-1 may be a prognostic marker in early stage breast cancer.
Test Resources
None found for this test
Please visit our Clinical Education Center to stay informed on any future publications, webinars, or other education opportunities.
Please visit our Clinical Education Center to stay informed on any future publications, webinars, or other education opportunities.
Test Details
Methodology
Enzyme Immunoassay (EIA)
Reference Range(s)
4-43 ng/mL
Alternative Name(s)
PAI-1
Preferred Specimen(s)
1 mL frozen plasma collected in a 3.2% sodium citrate (light blue-top) tube
Minimum Volume
0.5 mL
Transport Container
Transport tube
Transport Temperature
Frozen
Specimen Stability
- Room temperature: Unacceptable
- Refrigerated: 2 hours
- Frozen -20° C: 30 days
- Frozen -70° C: 1 year
Reject Criteria
Received thawed • Received room temperature • Received refrigerated
Setup Schedule
1 mL frozen plasma collected in a 3.2% sodium citrate (light blue-top) tube
0.5 mL
Transport tube
Frozen
Room temperature: Unacceptable
Refrigerated: 2 hours
Frozen -20° C: 30 days
Frozen -70° C: 1 year
Refrigerated: 2 hours
Frozen -20° C: 30 days
Frozen -70° C: 1 year
Received thawed • Received room temperature • Received refrigerated